Sandy Spring Bank’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-202
Closed -$5K 865
2016
Q4
$5K Hold
202
﹤0.01% 742
2016
Q3
$6K Hold
202
﹤0.01% 720
2016
Q2
$5K Hold
202
﹤0.01% 775
2016
Q1
$7K Hold
202
﹤0.01% 751
2015
Q4
$6K Hold
202
﹤0.01% 754
2015
Q3
$6K Buy
+202
New +$9.86K ﹤0.01% 744

Other funds holding PGEN

Sandy Spring Bank's PGEN Position: Q1 2017 in Review

Sandy Spring Bank sold out of Precigen (PGEN) in Q1 2017, closing a stake of 202 shares — an estimated $5K sold.

Sandy Spring Bank first reported a position in PGEN in Q3 2015 and held it in 6 quarters. The position peaked at $7K in Q1 2016. 154 funds tracked by Wall St. Rank hold PGEN as of Q1 2017.

  • Sandy Spring Bank reported no remaining Precigen position as of Q1 2017 after selling out during the quarter.
  • Sandy Spring Bank sold 202 Precigen shares in Q1 2017, an estimated $5K.
  • Sandy Spring Bank first reported a position in Precigen in Q3 2015 and held it in 6 quarters.
  • Sandy Spring Bank's Precigen position peaked at $7K in Q1 2016.
  • 154 funds tracked by Wall St. Rank held Precigen as of Q1 2017.

Based on Sandy Spring Bank's 13F filing for Q1 2017, filed 10 May 2017.